MT027

· Suzhou Maximum Bio-tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MT027, covering 2024-12-10 to 2025-06-04. Get the full timeline:

Most recent: Clinical Trial Update: MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors [NA]